Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2021-10-19 08:22:17
As COVID-19 vaccine output estimated to reach over 12 billion by year end and 24 billion by mid-2022, innovative vaccine manufacturers renew commitment to support G20 efforts to address remaining barriers to equitable access
This month, COVID-19 vaccine manufacturing output will pass the 9.3 billion dose mark. The biopharmaceutical industry renews its May commitment ...
Read More2021-09-28 12:28:43
African research foundation partners with international pharmaceutical industry to strengthen capacity for health innovation in Africa
28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers ...
Read More2021-09-16 11:58:09
Meet Africa’s New Generation of Health Innovators
Dakar, Senegal, 16 September 2021– The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) ...
Read More2021-09-13 14:30:58
IFPMA and Speak Up Africa announce winners of Africa Young Innovators for Health Award
Dakar, Senegal, 13 September 2021– The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and ...
Read More2021-09-07 12:20:13
Momentum of COVID-19 vaccine manufacturing scale up sufficient for step change in distribution
This month COVID-19 vaccine manufacturing output will pass the 7.5 billion dose mark. Vaccine manufacturers ...
Read More2021-06-22 15:01:46
New Non-State Actors Alliance calls on behalf of patients, industry for urgent action to set up the African Medicines Agency by the end of 2021
22 June – Paris/Geneva/London – Ministers of Health from four African countries (Algeria, Democratic Republic ...
Read More2021-06-22 06:37:18
Biopharmaceutical CEO Brussel meeting with EU leaders focuses on equitable access to tackle COVID-19, fostering innovation and unmet needs
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading ...
Read More
Latest Statement
2021-09-22 15:00:31
IFPMA EFPIA PhRMA BIO ABPI Statement - Global COVID-19 Summit: Ending the Pandemic and Building Back Better
Innovative biopharmaceutical companies are at the forefront of the response to the pandemic; not least by developing and manufacturing COVID-19 ...
Read More2021-09-21 15:00:33
IFPMA Statement at 76th Session of the UN General Assembly
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), ...
Read More2021-09-13 09:51:06
Report of the Pan-European Commission on Health and Sustainable Development at the WHO EURO 71st Regional Committee: Presentation of recommendations and conclusions
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), ...
Read More2021-08-24 16:41:06
IFPMA Statement at the 11th APEC High-level Meeting on Health and the Economy - Session title: Incorporating Health Equity into Trade and Supply Chains for Vaccines and Medical Products
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), ...
Read More2021-08-24 14:58:38
IFPMA Statement at the 71st session of the WHO Regional Committee for Africa: Special Event on the COVID-19 Response in the WHO AFRO Region
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), ...
Read More2021-07-21 18:59:26
IFPMA Statement at WTO-WHO High Level Dialogue “Expanding COVID-19 Vaccine Manufacture to Promote Equitable Access” – Session title: Looking ahead
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), ...
Read More2021-07-15 08:52:02
COVAX launches Marketplace to match buyers and sellers of critical manufacturing suppliers and speed up global access to COVID-19 vaccines through COVAX
Brussels, 22 June 2021 – The Biopharmaceutical CEO Roundtable (BCR), ...
Read More
mailto:a.jones@ifpma.org
Abigail Jones - Director, Communications
Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.
mailto:m.depol@ifpma.org
Twitter @MorganePol
Morgane De Pol - Deputy Director, Communications
Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
News Release
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of
Read MoreOur Blog
Flu season 2021/22 is approaching: flu vaccination may be more important than ever to protect the most vulnerable
This oped was originally published on Pharma Boardroom on 29 September 2021. Last flu season was exceptionally mild because of the measures used to contain COVID-19, like physical distancing and masks. But what will the upcoming flu season look like? Natural immunity against flu is likely to be lower because of last year’s lockdowns and preventive measures, which had an impact on the circulation of the flu...
Read More
Joint action to combat neglected tropical diseases
This op-ed was originally published for Media Planet's Neglected Tropical Diseases campaign on 27 September 2021. The global burden of neglected tropical diseases (NTDs) affects over 1.7 billion people living in poverty, predominantly in South America, Africa and Asia. In the past decade, the global health community has made strides in controlling and eliminating NTDs – a group of diseases that can be painful and...
Read More
How do we better prepare for future pandemics?
This op-ed was originally published for Media Planet's Infectious Diseases campaign on 23 September 2021. With the world’s gaze focused on ramping up production and delivery of 11 billion safe and effective COVID-19 vaccine doses within a year, it is important that we turn an eye to the future. As we need to make provisions for adequate contact tracing and access to diagnosis and treatment...
Read MoreLatest Tweets
